Invention Grant
- Patent Title: Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
-
Application No.: US17015696Application Date: 2020-09-09
-
Publication No.: US11319327B2Publication Date: 2022-05-03
- Inventor: Daniel J. Canney , Benjamin E. Blass , Kevin M. Blattner , Douglas A. Pippin
- Applicant: Temple University—Of The Commonwealth System of Higher Education , Praeventix, LLC
- Applicant Address: US PA Philadelphia; US PA Exton
- Assignee: Temple University—Of The Commonwealth System of Higher Education,Praeventix, LLC
- Current Assignee: Temple University—Of The Commonwealth System of Higher Education,Praeventix, LLC
- Current Assignee Address: US PA Philadelphia; US PA Exton
- Agency: Proskauer Rose LLP
- Agent Fangli Chen
- Main IPC: C07D491/107
- IPC: C07D491/107 ; C07D221/00 ; C07D295/073 ; C07D309/08 ; C07D493/10 ; C07D513/04 ; C07F7/10 ; C07D413/10
Abstract:
Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
Public/Granted literature
- US20210238189A1 NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE Public/Granted day:2021-08-05
Information query
